NCCN 2018 Oncology Fellows Program: New Horizons in Quality Cancer Care™
The purpose of this well-regarded program is to educate future oncology leaders about the application of the NCCN Guidelines® to the management of significant cancer types and supportive care issues. The NCCN Oncology Fellows Program has established itself as a premier career-enhancing event for oncology fellows across the United States.
This educational program is designed to meet the educational needs of second- and third-year medical, surgical, and radiation oncology fellows.
Following this program, participants should be able to:
Multidisciplinary Approach to Treating Locally Advanced Lung Cancer
• Describe the different types of multimodality treatment for patients with locally advanced or stage III NSCLC.
• Discuss how to determine whether patients with stage III NSCLC are candidates for surgery.
• Identify the pros and cons of neoadjuvant therapy for patients with stage III NSCLC.
Principles of Dose Modification for Organ Dysfunction
• Identify the clinical presentation and types of renal and/or hepatic dysfunction caused by commonly used oncology systemic therapies.
• Discuss prevention and monitoring strategies for chemotherapy-induced liver and renal toxicity.
• Describe the currently recommended dose adjustments for common systemic therapies in oncology patients with liver or renal dysfunction.
Continuum of Care for Patients with CLL
• Describe the current standard of care for newly diagnosed and relapsed/refractory CLL.
• Select the optimal first-line therapy for newly diagnosed CLL based on individual patient and disease characteristics (age, comorbidities and mutation status).
• Develop an appropriate treatment plan for sequencing of therapy in patients with relapsed/refractory CLL based on prior treatment and mutation status.
Esophageal Cancers – Treatment of Adenocarcinoma vs. Squamous Cell Carcinoma
• List key differences between esophageal SCC and adenocarcinoma that influence therapeutic approach.
• Outline current therapeutic strategies to treat esophageal SCC and adenocarcinoma.
• Identify future needs for the successful management of esophageal SCC and adenocarcinoma.
Overview of Germ Cell Tumors – Clinical Manifestation and Management of Testicular Germ Cell Tumors
• List key factors for both seminoma and nonseminomatous germ cell tumors that dictate disease management.
• Outline current management strategies for testicular germ cell tumors.
• Identify novel or emerging treatment strategies for metastatic/recurrent testicular germ cell tumors.
Developing a Research Program
• Discuss the challenges that early career scientists face when developing a research program.
• Describe strategies for balancing clinical activities and research, as well as negotiating protected time for research activities.
• Identify funding mechanisms for research and resources for grant writing and guidance on proper conduct of clinical trials.
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.